P

Pharmaniaga Bhd
KLSE:PHARMA

Watchlist Manager
Pharmaniaga Bhd
KLSE:PHARMA
Watchlist
Price: 0.36 MYR -1.37%
Market Cap: 518.8m MYR
Have any thoughts about
Pharmaniaga Bhd?
Write Note

Intrinsic Value

The intrinsic value of one PHARMA stock under the Base Case scenario is 0.82 MYR. Compared to the current market price of 0.36 MYR, Pharmaniaga Bhd is Undervalued by 56%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PHARMA Intrinsic Value
0.82 MYR
Undervaluation 56%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation Backtest
Pharmaniaga Bhd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PHARMA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PHARMA?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Pharmaniaga Bhd

Provide an overview of the primary business activities
of Pharmaniaga Bhd.

What unique competitive advantages
does Pharmaniaga Bhd hold over its rivals?

What risks and challenges
does Pharmaniaga Bhd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pharmaniaga Bhd.

Provide P/S
for Pharmaniaga Bhd.

Provide P/E
for Pharmaniaga Bhd.

Provide P/OCF
for Pharmaniaga Bhd.

Provide P/FCFE
for Pharmaniaga Bhd.

Provide P/B
for Pharmaniaga Bhd.

Provide EV/S
for Pharmaniaga Bhd.

Provide EV/GP
for Pharmaniaga Bhd.

Provide EV/EBITDA
for Pharmaniaga Bhd.

Provide EV/EBIT
for Pharmaniaga Bhd.

Provide EV/OCF
for Pharmaniaga Bhd.

Provide EV/FCFF
for Pharmaniaga Bhd.

Provide EV/IC
for Pharmaniaga Bhd.

Show me price targets
for Pharmaniaga Bhd made by professional analysts.

What are the Revenue projections
for Pharmaniaga Bhd?

How accurate were the past Revenue estimates
for Pharmaniaga Bhd?

What are the Net Income projections
for Pharmaniaga Bhd?

How accurate were the past Net Income estimates
for Pharmaniaga Bhd?

What are the EPS projections
for Pharmaniaga Bhd?

How accurate were the past EPS estimates
for Pharmaniaga Bhd?

What are the EBIT projections
for Pharmaniaga Bhd?

How accurate were the past EBIT estimates
for Pharmaniaga Bhd?

Compare the revenue forecasts
for Pharmaniaga Bhd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pharmaniaga Bhd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pharmaniaga Bhd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pharmaniaga Bhd compared to its peers.

Compare the P/E ratios
of Pharmaniaga Bhd against its peers.

Discuss the investment returns and shareholder value creation
comparing Pharmaniaga Bhd with its peers.

Analyze the financial leverage
of Pharmaniaga Bhd compared to its main competitors.

Show all profitability ratios
for Pharmaniaga Bhd.

Provide ROE
for Pharmaniaga Bhd.

Provide ROA
for Pharmaniaga Bhd.

Provide ROIC
for Pharmaniaga Bhd.

Provide ROCE
for Pharmaniaga Bhd.

Provide Gross Margin
for Pharmaniaga Bhd.

Provide Operating Margin
for Pharmaniaga Bhd.

Provide Net Margin
for Pharmaniaga Bhd.

Provide FCF Margin
for Pharmaniaga Bhd.

Show all solvency ratios
for Pharmaniaga Bhd.

Provide D/E Ratio
for Pharmaniaga Bhd.

Provide D/A Ratio
for Pharmaniaga Bhd.

Provide Interest Coverage Ratio
for Pharmaniaga Bhd.

Provide Altman Z-Score Ratio
for Pharmaniaga Bhd.

Provide Quick Ratio
for Pharmaniaga Bhd.

Provide Current Ratio
for Pharmaniaga Bhd.

Provide Cash Ratio
for Pharmaniaga Bhd.

What is the historical Revenue growth
over the last 5 years for Pharmaniaga Bhd?

What is the historical Net Income growth
over the last 5 years for Pharmaniaga Bhd?

What is the current Free Cash Flow
of Pharmaniaga Bhd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pharmaniaga Bhd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pharmaniaga Bhd

Current Assets 1.3B
Cash & Short-Term Investments 66.8m
Receivables 610.2m
Other Current Assets 596m
Non-Current Assets 806.6m
PP&E 603.2m
Intangibles 151.1m
Other Non-Current Assets 52.3m
Current Liabilities 2.2B
Accounts Payable 1B
Short-Term Debt 756.5m
Other Current Liabilities 397.2m
Non-Current Liabilities 197.6m
Long-Term Debt 127.7m
Other Non-Current Liabilities 69.9m
Efficiency

Earnings Waterfall
Pharmaniaga Bhd

Revenue
3.5B MYR
Cost of Revenue
-3.2B MYR
Gross Profit
323.6m MYR
Operating Expenses
-308.5m MYR
Operating Income
15.1m MYR
Other Expenses
-71.4m MYR
Net Income
-56.3m MYR

Free Cash Flow Analysis
Pharmaniaga Bhd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PHARMA Profitability Score
Profitability Due Diligence

Pharmaniaga Bhd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Exceptional ROE
ROE is Increasing
Positive 3-Years Revenue Growth
Positive Gross Profit
34/100
Profitability
Score

Pharmaniaga Bhd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

PHARMA Solvency Score
Solvency Due Diligence

Pharmaniaga Bhd's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
31/100
Solvency
Score

Pharmaniaga Bhd's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PHARMA Price Targets Summary
Pharmaniaga Bhd

Wall Street analysts forecast PHARMA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHARMA is 0.35 MYR with a low forecast of 0.34 MYR and a high forecast of 0.36 MYR.

Lowest
Price Target
0.34 MYR
5% Downside
Average
Price Target
0.35 MYR
4% Downside
Highest
Price Target
0.36 MYR
1% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PHARMA?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PHARMA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Pharmaniaga Bhd

Country

Malaysia

Industry

Health Care

Market Cap

526m MYR

Dividend Yield

0%

Description

Pharmaniaga Bhd.operates as an investment holding company. The company is headquartered in Shah Alam, Selangor. The firm is principally engaged in the research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales, and marketing, as well as community pharmacy. The Company’s segment includes Logistics and distribution, Manufacturing, and Indonesia. The Logistics and distribution segment is engaged in the distribution, trading, and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment is involved in manufacturing of pharmaceutical products in Malaysia. The Indonesia segment is engaged manufacturing and distribution of pharmaceutical and medical products in Indonesia. Its subsidiaries include Idaman Pharma Manufacturing Sdn. Bhd., Pharmaniaga Manufacturing Berhad, Pharmaniaga LifeScience Sdn. Bhd., Pharmaniaga Logistics Sdn. Bhd., and Pharmaniaga Marketing Sdn. Bhd.

Contact

SELANGOR
Shah Alam
No. 7, Lorong Keluli 1B, Kawasan Perindustrian, Bukit Raja Selatan, Seksyen 7
+60333429999
www.pharmaniaga.com

IPO

1999-11-12

Employees

3 642

Officers

Deputy CEO & Managing Director
Mr. Zulkifli Bin Jafar
Chief Financial Officer
Ms. Norai'ni Binti Mohamed Ali
COO & Director
Mr. Ahmad Shahredzuan Bin Mohd Shariff
Chief Scientific Officer
Dr. Badarulhisam Abdul Rahman
Executive Vice President of Logistics & Distribution Division
Mr. Abdul Malik Mohamed
Executive Vice President of Commercial Division
Mr. Zulhazri bin Razali
Show More
Executive VP of Corporate Governance & Company Secretary
Ms. Wan Intan Idura Wan Ismail
Chief People Officer
Ms. Azni Hasan Basri
Chief Strategy Officer
Mr. Idham Ismail
Acting Head of Manufacturing Operations
Mr. Mohd Izwan Ishak
Show Less

See Also

Discover More
What is the Intrinsic Value of one PHARMA stock?

The intrinsic value of one PHARMA stock under the Base Case scenario is 0.82 MYR.

Is PHARMA stock undervalued or overvalued?

Compared to the current market price of 0.36 MYR, Pharmaniaga Bhd is Undervalued by 56%.

Back to Top